Literature DB >> 11356312

Allosteric modulation in spontaneously active mutant gamma-aminobutyric acidA receptors.

G S Findlay1, S Ueno, N L Harrison, R A Harris.   

Abstract

Tryptophan substitutions were made in the second transmembrane domain of the gamma-aminobutyric acid(A) (GABAA) receptor alpha and beta subunits and the resulting mutant receptors, containing alpha2(S270W) and/or beta1 (S265W), were expressed in Xenopus oocytes. Mutation of either or both subunits resulted in receptors that exhibited enhanced sensitivity to agonist and were spontaneously active in the absence of GABA. The spontaneous activity was blocked by picrotoxin or bicuculline. The enhancement of GABA-induced currents by pentobarbital, by the neurosteroid 5alpha-pregnan-3alpha-ol-20-one, and by the benzodiazepine flunitrazepam was dramatically reduced in the mutant receptors. These results are consistent with the idea that a mutation that promotes gating behavior in a ligand-gated ion channel will also show reduced effects of all positive allosteric modulators in a generalized manner, even when these modulators act at distinct sites on the receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356312     DOI: 10.1016/s0304-3940(01)01646-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  GABA(A) receptors and alcohol.

Authors:  Ingrid A Lobo; R Adron Harris
Journal:  Pharmacol Biochem Behav       Date:  2008-03-14       Impact factor: 3.533

2.  Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.

Authors:  Deirdre Stewart; Rooma Desai; Qi Cheng; Aiping Liu; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2008-09-19       Impact factor: 4.436

Review 3.  Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Curr Opin Anaesthesiol       Date:  2012-08       Impact factor: 2.706

4.  Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites.

Authors:  A V Kalueff
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

5.  A residue in loop 9 of the beta2-subunit stabilizes the closed state of the GABAA receptor.

Authors:  Carrie A Williams; Shannon V Bell; Andrew Jenkins
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  Cross-linking of sites involved with alcohol action between transmembrane segments 1 and 3 of the glycine receptor following activation.

Authors:  Ingrid A Lobo; R Adron Harris; James R Trudell
Journal:  J Neurochem       Date:  2007-11-23       Impact factor: 5.372

7.  The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.

Authors:  Xiang-Qun Hu; David M Lovinger
Journal:  Neuropharmacology       Date:  2008-03-27       Impact factor: 5.250

8.  Mutations of L293 in transmembrane two of the mouse 5-hydroxytryptamine3A receptor alter gating and alcohol modulatory actions.

Authors:  Xiang-Qun Hu; Volodya Hayrapetyan; Jay J Gadhiya; Heather E Rhubottom; David M Lovinger; Tina K Machu
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

9.  Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant.

Authors:  Geoffrey S Findlay; Rachel Phelan; Michael T Roberts; Gregg E Homanics; Susan E Bergeson; Gregory F Lopreato; S John Mihic; Yuri A Blednov; R Adron Harris
Journal:  J Neurosci       Date:  2003-09-03       Impact factor: 6.167

10.  Contrasting Effects of the γ-Aminobutyric Acid Type A Receptor β3 Subunit N265M Mutation on Loss of Righting Reflexes Induced by Etomidate and the Novel Anesthetic Barbiturate R-mTFD-MPAB.

Authors:  Corey A Amlong; Mark G Perkins; Timothy T Houle; Keith W Miller; Robert A Pearce
Journal:  Anesth Analg       Date:  2016-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.